STAT September 17, 2025
Semler Scientific will also lose a ‘significant’ customer, potentially halving its revenue
Semler Scientific will pay the Department of Justice nearly $30 million to settle health care fraud claims related to its peripheral artery disease test, QuantaFlo — a device used by UnitedHealth Group and other large Medicare Advantage insurers.
The company also said that a significant customer, which accounted for nearly half of its revenue in the second quarter of 2025, is rolling back its use of QuantaFlo starting in October....







